- Hem
- Om universitetet
- Hitta person
- Marcus Lind
Marcus Lind
Om Marcus Lind
Läs mer om Marcus Lind och hans forskning (på engelska) här.
-
Design and methods of the Ixekizumab Diabetes Intervention Trial (I-DIT): protocol for a phase 2, randomised, multicentre, placebo-controlled, double-blind trial of anti-interleukin 17 as a treatment option for adults with new-onset type 1
diabetes
Shilan Seyed Ahmadi, Olle Korsgren, Per-Anders Jansson, Marcus Lind
BMJ OPEN - 2025 -
Type 2 diabetes, sodium-glucose cotransporter-2 inhibitors and cardiovascular outcomes: real world evidence versus a randomised clinical
trial
Puriya Daniel Wurtz Yazdanfard, Kathrine Kold Sorensen, Bochra Zareini, Ulrik Pedersen-Bjergaard, Johan Sebastian Ohlendorff, Anders Munch, Mikkel Porsborg Andersen, Rasmus Bo Hasselbalch, Henrik Imberg, Viktor Tasselius, Marcus Lind, Jonathan Valabhji, Pratik Choudhary, Kamlesh Khunti, Stefanie Schmid, Stefanie Lanzinger, Julia Mader, Thomas Alexander Gerds, Christian Torp-Pedersen
CARDIOVASCULAR DIABETOLOGY - 2025 -
Toward a Clinically Actionable, Electronic Health Record- Based Machine Learning Model to Forecast 90-Day Change in Hemoglobin A<sub>1c</sub> in Youth With Type 1 Diabetes: Feasibility and Model Development
Study
Erin M. Tallon, David Williams, Cintya Schweisberger, Colin Mullaney, Brent Lockee, Diana Ferro, Craig A. Vandervelden, Mitchell S. Barnes, Angelica Cristello Sarteau, Anna R. Kahkoska, Susana R. Patton, Sanjeev Mehta, Ryan Mcdonough, Marcus Lind, Leonard D'Avolio, Mark A. Clements
JMIR DIABETES - 2025 -
Systematic intensive therapy in addition to continuous glucose monitoring in adults with type 1 diabetes: a multicentre, open-label, randomised controlled
trial
Arndis Finna Olafsdottir, Kari-Anne Sveen, Magnus Wijkman, Sara Hallström, Per-Henrik Nilsson, Sofia Sterner Isaksson, Helene Holmer, Marie Ekstrom, Henrik Imberg, Marcus Lind
LANCET REGIONAL HEALTH-EUROPE - 2025 -
Real-world cardiovascular effectiveness of sustained glucagon-like peptide 1 GLP-1 receptor agonist usage in type 2
diabetes
Kathrine Kold Sorensen, Puriya Daniel Wurtz Yazdanfard, Bochra Zareini, Ulrik Pedersen-Bjergaard, Vanja Kosjerina, Mikkel Porsborg Andersen, Anders Munch, Johan Sebastian Ohlendorff, Stefanie Schmid, Stefanie Lanzinger, Pratik Choudhary, Clare Gillies, Safoora Gharibzadeh, Marcus Lind, Viktor Tasselius, Jens Michelsen, Thomas Alexander Gerds, Christian Torp-Pedersen
CARDIOVASCULAR DIABETOLOGY - 2025 -
A cohort description and comparison of four European national diabetes registries for the REDDIE
project
Jonah J. C. Thomas, Stefanie Lanzinger, Kathrine Kold Soerensen, Henrik Imberg, Stefanie Schmid, Emma Barron, Reinhard Holl, Ulrik Pedersen-Bjergaard, Amanda Adler, Martina Vettoretti, Shivani Misra, Jonathan Valabhji, Kamlesh Khunti, Marcus Lind, Christian Torp-Pedersen, Julia K. Mader, Pratik Choudhary
DIABETIC MEDICINE - 2025 -
Retinopathy and nephropathy in type 1 diabetes: role of HbA1c and blood pressure
variability
Pavel Jamal Fatulla, Johnny Ludvigsson, Henrik Imberg, Thomas Nystrom, Marcus Lind
ACTA DIABETOLOGICA - 2025 -
Increased tumor necrosis factor-receptor superfamily plasma levels are associated with early renal or retinal involvement in intermediate
hyperglycemia
Sebastian Mas-Fontao, Esther Civantos, Nisa Boukichou-Abdelkader, Juan Antonio Moreno, Carmen Gomez-Guerrero, M. Isabel Lopez Galvez, Jaakko Tuomilehto, Marcus Lind, Rafael Gabriel, Jesus Egido
WORLD JOURNAL OF DIABETES - 2025 -
Accuracy of Glucose Trends by Subcutaneous Continuous Monitoring vs Intermittent Arterial Measurements in Critically Ill
Patients
Ola Friman, Marcus Lind, Ragnar Thobaben, Pia Zetterqvist, Anders Perner, Olav Rooijackers, Anders Oldner, Johan Mårtensson
Journal of Diabetes Science and Technology - 2025 -
Design and methods of a multicenter randomized clinical trial of effects of diabetes-educated psychologist on glucose management and diabetes
distress
Johanna Zeijlemaker, Therese Anderbro, Sofia Sterner Isaksson, Marcus Lind
Frontiers in Clinical Diabetes and Healthcare - 2025 -
Prevention of glucocorticoid-induced impairment of bone metabolism - a randomized, placebo-controlled, single centre proof-of-concept clinical
trial
Giulia Gregori, Lisa Johansson, Lena Silberberg, Henrik Imberg, Per Magnusson, Marcus Lind, Mattias Lorentzon
JBMR Plus - 2025 -
Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized
Trial
Daniel Pylov, W. Polonsky, Henrik Imberg, H. Holmer, J. Hellman, M. Wijkman, J. Bolinder, T. Heisse, S. Dahlqvist, T. Nystrom, E. Schwarz, I. Hirsch, Marcus Lind
Journal of Diabetes Science and Technology - 2025 -
Risk Factors for Retinopathy in Young Adults With Type 1
Diabetes
Shilan Seyed Ahmadi, Johnny Ludvigsson, Henrik Imberg, Thomas Nystroem, Marcus Lind
JAMA OPHTHALMOLOGY - 2025 -
Evaluating the Adequacy of Coefficient of Variation and Standard Deviation as Metrics of Glucose Variability in Type 1 Diabetes Based on Data from the GOLD and SILVER
Trials
Pavel Jamal Fatulla, Henrik Imberg, Sofia Sterner Isaksson, Irl B. Hirsch, Johan Martensson, Hanna Liljeback, Tim Heise, Marcus Lind
DIABETES TECHNOLOGY & THERAPEUTICS - 2025 -
Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and
Diabetes
Connie M. Rhee, Roma Y. Gianchandani, David Kerr, Athena Philis-Tsimikas, Csaba P. Kovesdy, Robert C. Stanton, Andjela T. Drincic, Rodolfo J. Galindo, Kamyar Kalantar-Zadeh, Joshua J. Neumiller, Ian H. de Boer, Marcus Lind, Sun H. Kim, Alessandra T. Ayers, Cindy N. Ho, Rachel E. Aaron, Tiffany Tian, David C. Klonoff
Journal of Diabetes Science and Technology - 2025 -
Insulin requirement trajectories during COVID-19 versus non-COVID-19 critical illness-A retrospective cohort
study
Navid Soltani, Henrike Habel, Anca Balintescu, Marcus Lind, Jonathan Grip, Ragnar Thobaben, David Nelson, Johan Martensson
ACTA ANAESTHESIOLOGICA SCANDINAVICA - 2025 -
Inhibition of leukotrienes and their potential role in type 1 diabetes pathogenesis: implications for montelukast as a therapeutic agent: a case
report
Pavel Jamal Fatulla, Ingela Strom, Christine Lingblom, Marcus Lind
FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE - 2024 -
The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose
Monitors
David C. Klonoff, Guido Freckmann, Stefan Pleus, Boris P. Kovatchev, David Kerr, Chui Tse, Chengdong Li, Michael S.D. Agus, Kathleen Dungan, Barbora Voglová Hagerf, Jan S. Krouwer, Wei An Lee, Shivani Misra, Sang Youl Rhee, Ashutosh Sabharwal, Jane Jeffrie Seley, Viral N. Shah, Nam K. Tran, Kayo Waki, Chris Worth, Tiffany Tian, Rachel E. Aaron, Keetan Rutledge, Cindy N. Ho, Alessandra T. Ayers, Amanda Adler, David T. Ahn, Halis Kaan Aktürk, Mohammed E. Al-Sofiani, Timothy S. Bailey, Matt Baker, Lia Bally, Raveendhara R. Bannuru, Elizabeth M. Bauer, Yong Mong Bee, Julia E. Blanchette, Eda Cengiz, James Geoffrey Chase, Kong Y. Chen, Daniel Cherñavvsky, Mark Clements, Gerard L. Cote, Ketan K. Dhatariya, Andjela Drincic, Niels Ejskjaer, Juan Espinoza, Chiara Fabris, G. Alexander Fleming, Monica A.L. Gabbay, Rodolfo J. Galindo, Ana María Gómez-Medina, Lutz Heinemann, Norbert Hermanns, Thanh Hoang, Sufyan Hussain, Peter G. Jacobs, Johan Jendle, Shashank R. Joshi, Suneil K. Koliwad, Rayhan A. Lal, Lawrence A. Leiter, Marcus Lind, Julia K. Mader, Alberto Maran, Umesh Masharani, Nestoras Mathioudakis, Michael McShane, Chhavi Mehta, Sun Joon Moon, James H. Nichols, David N. O’Neal, Francisco J. Pasquel, Anne L. Peters, Andreas Pfützner, Rodica Pop-Busui, Pratistha Ranjitkar, Connie M. Rhee, David B. Sacks, Signe Schmidt, Simon M. Schwaighofer, Bin Sheng, Gregg D. Simonson, Koji Sode, Elias K. Spanakis, Nicole L. Spartano, Guillermo E. Umpierrez, Maryam Vareth, Hubert W. Vesper, Jing Wang, Eugene Wright, Alan H.B. Wu, Sewagegn Yeshiwas, Mihail Zilbermint, Michael A. Kohn
Journal of Diabetes Science and Technology - 2024 -
Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin
Glargine
Donald C. Simonson, Marcia A. Testa, Ella Ekholm, Maxwell Su, Tina Vilsboll, Serge A. Jabbour, Marcus Lind
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM - 2024 -
Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD
8)
T. Nyström, E. Schwarz, Sofia Dahlqvist, M. Wijkman, M. Ekelund, H. Holmer, J. Bolinder, J. Hellman, Henrik Imberg, I. B. Hirsch, Marcus Lind
Journal of Diabetes Science and Technology - 2024 -
Prevalence and risk factors for diabetic retinopathy at diagnosis of type 2 diabetes: an observational study of 77 681 patients from the Swedish National Diabetes
Registry
Sheyda Sofizadeh, Katarina Eeg-Olofsson, Marcus Lind
BMJ OPEN DIABETES RESEARCH & CARE - 2024 -
Performance of Subcutaneous Continuous Glucose Monitoring in Adult Critically Ill Patients Receiving Vasopressor
Therapy
Ola Friman, Navid Soltani, Marcus Lind, Pia Zetterqvist, Anca Balintescu, Anders Perner, Anders Oldner, Olav Rooyackers, Johan Martensson
DIABETES TECHNOLOGY & THERAPEUTICS - 2024 -
Trends in Survival After First Myocardial Infarction in People With
Diabetes
Linn Glynn, Marcus Lind, Tomas Andersson, Bjoern Eliasson, Robin Hofmann, Thomas Nystroem
JOURNAL OF THE AMERICAN HEART ASSOCIATION - 2024 -
Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER
trials
Sofia Sterner Isaksson, Henrik Imberg, Irl B. Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Wijkman, Jan Bolinder, Thomas Nystrom, Helene Holmer, Sara Hallström, Arndis Olafsdottir, Sofia Pekkari, William Polonsky, Marcus Lind
DIABETOLOGIA - 2024 -
Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1
Diabetes
Ramanjit Singh, Henrik Imberg, Shilan Seyed Ahmadi, Sara Hallström, Johan Jendle, Bengt-Olov Tengmark, Anna Folino, Ekstrom Marie, Marcus Lind
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY - 2024 -
The effect of carbohydrate intake on glycaemic control in individuals with type 1 diabetes: a randomised, open-label, crossover
trial
Sofia Sterner Isaksson, Arndis Olafsdottir, Simon Ivarsson, Henrik Imberg, Eva Toft, Sara Hallström, Ulf Rosenqvist, Marie Ekstrom, Marcus Lind
LANCET REGIONAL HEALTH-EUROPE - 2024 -
An "All-Data-on-Hand" Deep Learning Model to Predict Hospitalization for Diabetic Ketoacidosis in Youth With Type 1 Diabetes: Development and Validation
Study
Colin Mullaney, David D. Williams, Diana Ferro, Lydia Skrabonja, Mitchell S. Barnes, Susana R. Patton, Brent Lockee, Erin M. Tallon, Craig A. Vandervelden, Cintya Schweisberger, Sanjeev Mehta, Ryan McDonough, Marcus Lind, Leonard D'Avolio, Mark A. Clements
JMIR Diabetes - 2023 -
Evaluating a systematic intensive therapy using continuous glucose monitoring and intermittent scanning glucose monitoring in clinical diabetes care: a protocol for a multi-center randomized clinical
trial
Arndís F. Ólafsdóttir, Marcus Lind
Frontiers in Clinical Diabetes and Healthcare - 2023 -
Mortality in Patients With Primary Aldosteronism: A Swedish Nationwide
Study.
Eleftheria Gkaniatsa, Tatiana Zverkova Sandström, Annika Rosengren, Penelope Trimpou, Daniel S Olsson, Marcus Lind, Andreas Muth, Gudmundur Johannsson, Oskar Ragnarsson
Hypertension (Dallas, Tex. : 1979) - 2023 -
Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database
Study
Marcus Lind, S. B. Catrina, N. R. Ekberg, S. Gerward, T. Halasa, J. Hellman, D. Hess, M. Londahl, V. Qvist, J. Bolinder
Diabetes Therapy - 2023 -
Investigating immune profile by CyTOF in individuals with long-standing type 1
diabetes
Helen Larsson, Sofie Albinsson, Marcus Lind, Hardis Rabe, Christine Lingblom
SCIENTIFIC REPORTS - 2023 -
Design of a randomized cross-over study evaluating effects of carbohydrate intake on glycemic control in persons with type 1
diabetes
Sofia Sterner Isaksson, Arndís F. Ólafsdóttir, Marcus Lind
Frontiers in Nutrition - 2023 -
Diabetes status and other factors as correlates of risk for thrombotic and thromboembolic events during SARS-CoV-2 infection: A nationwide retrospective case-control study using Cerner Real-World Data &
TRADE
E. M. Tallon, M. P. Gallagher, V. S. Staggs, D. Ferro, D. B. Murthy, O. Ebekozien, M. N. Kosiborod, Marcus Lind, C. Manrique-Acevedo, C. R. Shyu, M. A. Clements
Bmj Open - 2023 -
Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in
Sweden.
Jon Edqvist, Christina Lundberg, Karin Andréasson , Lena Björck, Pigi Dikaiou, Johnny Ludvigsson, Marcus Lind, Martin Adiels, Annika Rosengren
Diabetes care - 2023 -
Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the
UK
A. Gonzalez Perez, D. Vizcaya, M. E. Sáez, Marcus Lind, L. A. Garcia Rodriguez
BMJ open diabetes research & care - 2023 -
Glycemic control and outcome after carotid intervention in patients with T2D: A Swedish nationwide cohort
study
A. Zabala, A. Gottsaeter, Marcus Lind, Björn Eliasson, R. Bertilsson, J. Ekelund, M. Jonsson, T. Nystroem
Diabetes & Vascular Disease Research - 2023 -
Glycaemic control and sepsis risk in adults with type 1
diabetes
A. Balintescu, Marcus Lind, M. A. Franko, A. Oldner, M. Cronhjort, B. Eliasson, C. Svensen, J. Martensson
Diabetes Obesity & Metabolism - 2023 -
Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled
Trial
R. Gabriel, N. Boukichou-Abdelkader, A. Gilis-Januszewska, K. Makrilakis, R. Gomez-Huelgas, Z. Kamenov, B. Paulweber, I. Satman, P. Djordjevic, A. Alkandari, A. Mitrakou, N. Lalic, J. Egido, S. Mas-Fontao, J. H. Calvet, J. C. Pastor, J. Lindstrom, Marcus Lind, T. Acosta, L. Silva, J. Tuomilehto
Journal of Clinical Medicine - 2023 -
Estimated glucose disposal rate is associated with retinopathy and kidney disease in young people with type 1 diabetes: a nationwide observational
study
W. Linn, M. Persson, B. Rathsman, J. Ludvigsson, Marcus Lind, M. A. Franko, T. Nystrom
Cardiovascular Diabetology - 2023 -
Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents and adults with recently diagnosed type 1 diabetes, carrying the genetic HLA DR3-DQ2 haplotype: the DIAGNODE-3 study
protocol
J. Ludvigsson, L. Eriksson, C. Nowak, P. F. Teixeira, M. Widman, A. Lindqvist, R. Casas, Marcus Lind, U. Hannelius
Bmj Open - 2022 -
Performance of Dexcom G5 and FreeStyle Libre sensors tested simultaneously in people with type 1 or 2 diabetes and advanced chronic kidney
disease
Arndis Olafsdottir, M. Andelin, Aso Saeed, S. Sofizadeh, H. Hamoodi, Per-Anders Jansson, Marcus Lind
World Journal of Clinical Cases - 2022 -
Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2
Diabetes
A. Balintescu, Marcus Lind, M. A. Franko, A. Oldner, M. Cronhjort, Ann-Marie Svensson, Björn Eliasson, J. Mårtensson
Diabetes Care - 2022 -
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician
Ratings
J. C. Espinoza, D. C. Klonoff, J. Wang, D. Rodbard, M. A. Kohn, C. Li, D. Liepmann, D. Kerr, D. Ahn, A. L. Peters, G. E. Umpierrez, J. J. Seley, N. Y. Xu, K. T. Nguyen, G. Simonson, M. S. D. Agus, M. E. Al-Sofiani, G. Armaiz-Pena, T. S. Bailey, A. Basu, T. Battelino, S. Y. Bekele, P. Y. Benhamou, B. W. Bequette, T. Blevins, M. D. Breton, J. R. Castle, J. G. Chase, K. Y. Chen, P. Choudhary, M. A. Clements, K. L. Close, C. B. Cook, T. Danne, III Doyle, A. Drincic, K. M. Dungan, S. V. Edelman, N. Ejskjaer, G. A. Fleming, G. P. Forlenza, G. Freckmann, R. J. Galindo, A. M. Gomez, H. A. Gutow, L. Heinemann, I. B. Hirsch, T. D. Hoang, R. Hovorka, J. H. Jendle, L. Ji, S. R. Joshi, M. Joubert, S. K. Koliwad, R. A. Lal, M. C. Lansang, W. A. Lee, L. Leelarathna, L. A. Leiter, Marcus Lind, M. L. Litchman, J. K. Mader, K. M. Mahoney, B. Mankovsky, U. Masharani, N. N. Mathioudakis, A. Mayorov, J. Messler, J. D. Miller, V. Mohan, J. H. Nichols, K. Nørgaard, D. N. O’Neal, F. J. Pasquel, A. Philis-Tsimikas, T. Pieber, M. Phillip, W. H. Polonsky, R. Pop-Busui, G. Rayman, E. J. Rhee, S. J. Russell, V. N. Shah, J. L. Sherr, K. Sode, E. K. Spanakis, D. J. Wake, K. Waki, A. Wallia, M. E. Weinberg, H. Wolpert, E. E. Wright, M. Zilbermint, B. Kovatchev
Journal of Diabetes Science and Technology - 2022 -
Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin
injections
Klara Westman, Henrik Imberg, M. O. Wijkman, I. B. Hirsch, J. Tuomilehto, Sofia Dahlqvist, Marcus Lind
Journal of Diabetes and its Complications - 2022 -
Body mass index in adolescence, risk of type 2 diabetes and associated complications: A nationwide cohort study of
men
Karin Andréasson , Jon Edqvist, Martin Adiels, Lena Björck, Martin Lindgren, S. Naveed, Marcus Lind, Maria A I Åberg, Annika Rosengren
EClinicalMedicine - 2022 -
Intralymphatic GAD-Alum (Diamyd (R)) Improves Glycemic Control in Type 1 Diabetes With HLA
DR3-DQ2
C. Nowak, Marcus Lind, Z. Sumnik, T. Pelikanova, L. N. Chavez, E. Lundberg, I. Rica, M. A. Martinez-Brocca, M. S. R. de Adana, J. Wahlberg, R. Hanas, C. Hernandez, M. Clemente-Leon, A. Gomez-Gila, M. F. Lozano, T. Sas, S. Pruhova, F. Dietrich, S. P. Marin, U. Hannelius, R. Casas, J. Ludvigsson
Journal of Clinical Endocrinology & Metabolism - 2022 -
Risk factors for nephropathy in persons with type 1 diabetes: a population-based
study
Shilan Seyed Ahmadi, Aldina Pivodic, A. M. Svensson, Hans Wedel, B. Rathsman, T. Nystrom, J. Ludvigsson, Marcus Lind
Acta Diabetologica - 2022 -
Risk factors, mortality trends and cardiovasuclar diseases in people with Type 1 diabetes and controls: A Swedish observational cohort
study
Sara Hallström, M. O. Wijkman, J. Ludvigsson, P. Ekman, M. A. Pfeffer, Hans Wedel, Annika Rosengren, Marcus Lind
Lancet Regional Health-Europe - 2022 -
LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort
study
B. Rathsman, J. Haas, M. Persson, J. Ludvigsson, Ann-Marie Svensson, Marcus Lind, M. A. Franko, T. Nystrom
Journal of Internal Medicine - 2021 -
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial
(GOLD-5)
Arndis Olafsdottir, J. Bolinder, T. Heise, W. Polonsky, M. Ekelund, M. Wijkman, Aldina Pivodic, Elsa Ahlén, E. Schwarcz, T. Nystrom, J. Hellman, I. B. Hirsch, Marcus Lind
Diabetes Obesity & Metabolism - 2021
Fler publikationer
Antalet publikationer som visas på denna sida är begränsat. Besök Göteborgs Universitets publikationsdatabas (GUP) för att söka efter fler publikationer.